IL18 and neoplasm: Increasing evidence revealed that B-cell subsets in PDAC tumor microenvironment upregulate associated immunosuppressive cytokines (most notably, IL-10, IL-18, and IL-35) and immune checkpoint ligands (particularly PD-L1), contributing to oncogenesis and the inhibition of T cell-mediated tumor immunity (47).